What does Hemab Therapeutics Holdings, Inc. do?
Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience in United States of America and Denmark. Its products includes (HMB-001), is a bispecific antibody currently in…
What is Hemab Therapeutics Holdings, Inc.'s P/E and P/B ratio?
Hemab Therapeutics Holdings, Inc. has a P/E ratio of -8.0 and a P/B ratio of 3.58.
What is Hemab Therapeutics Holdings, Inc.'s debt-to-equity ratio?
Hemab Therapeutics Holdings, Inc. has a debt-to-equity ratio of 0.00.
How much does Hemab Therapeutics Holdings, Inc. owe compared with what it owns?
Hemab Therapeutics Holdings, Inc. owes $0.03 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Hemab Therapeutics Holdings, Inc.'s Positivity rank?
Hemab Therapeutics Holdings, Inc. is ranked #4,410 of 6,774 companies globally and #2,197 of 4,000 in United States on PositoAI, with a Positivity Score of 19,490.
Does Hemab Therapeutics Holdings, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Hemab Therapeutics Holdings, Inc..
Where can I read the latest news about Hemab Therapeutics Holdings, Inc.?
Recent headlines about Hemab Therapeutics Holdings, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Hemab Therapeutics Holdings, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Hemab Therapeutics Holdings, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.